11-TREO: A Phase II Study of Treosulfane/Fiudarabine/Low Dose Total Body Irradiation as a Preparative Regimen for Children with AMLIMDS Undergoing Allogeneic Hematopoietic Cell Transplantation

Grant

Date/time Interval

  • August 23, 2013 - March 23, 2017

    • Awarded By

    Total Award Amount

  • 43200.00

    • Direct Costs

  • 33882.00

    • Sponsor Award Id

    • Contributor

  • Frederick Goldman M.D.   Investigator  
  • Hilary Haines   Investigator  
  • Joseph Chewning III M.D.   Principal Investigator